Legal

Terms of Service

Effective: July 12, 2026  ·  Governing Law: State of Georgia, USA

1. Acceptance of Terms

By accessing or using BiotechSign (the "Service"), operated by Guerilla Finance Inc., you agree to be bound by these Terms of Service ("Terms"). These Terms constitute a legally binding agreement. If you do not agree, do not use the Service.

2. Description of Service

BiotechSign provides financial data, biotech scores, PDUFA calendars, clinical trial tracking, and signal aggregation for publicly traded biotechnology and pharmaceutical companies. The Service aggregates data from SEC EDGAR, FDA databases, ClinicalTrials.gov, and proprietary analytical models.

3. Not Financial or Medical Advice

BIOTECHSIGN DOES NOT PROVIDE INVESTMENT, FINANCIAL, MEDICAL, OR REGULATORY ADVICE. Clinical trial data, drug approval timelines, and PDUFA dates are informational only. FDA decisions are inherently unpredictable. Past approval patterns are not indicative of future outcomes. Biotech investments carry extreme risk including total loss of capital. Nothing on this platform constitutes a recommendation to buy, sell, or hold any security. Always consult a qualified financial advisor and independent medical or regulatory professionals before making any investment decision.

4. No Client Relationship

Your use of the Service does not create any advisory, fiduciary, broker, dealer, or client relationship between you and Guerilla Finance Inc. We do not act as your financial adviser or in any fiduciary capacity. We owe you no fiduciary duty, duty of loyalty, or duty of care in connection with your use of the Service or any investment or trading decisions you make. The Service is a data and research tool — the decision to act on any information is yours alone.

5. Market Risk Acknowledgment

By using the Service, you explicitly acknowledge and agree that:

  • Investing in securities involves substantial risk of loss, including the potential loss of your entire investment;
  • Financial markets are inherently volatile and unpredictable; past performance is not indicative of future results;
  • Biotech investments carry extreme and binary risk — FDA approval decisions can result in total loss of capital within a single trading session;
  • PDUFA dates, clinical trial timelines, and approval probabilities are estimates only and may change without notice;
  • FDA decisions cannot be predicted with certainty by any data platform, algorithm, or analyst;
  • No data, score, signal, or analysis on this platform predicts or guarantees future stock prices or regulatory outcomes;
  • You are solely responsible for independently evaluating the risks of any investment or trading decision.

6. User Responsibilities

You are solely responsible for:

  • All investment and trading decisions you make, regardless of any information obtained from the Service;
  • Conducting your own independent research and due diligence before making any investment decision;
  • Understanding the extreme risks associated with biotech investing, including the risk of total loss;
  • Compliance with all applicable laws, regulations, and rules governing your trading and investing activities;
  • Verifying PDUFA dates, clinical trial statuses, and FDA decisions from official primary sources;
  • Ensuring that your use of the Service complies with these Terms at all times.

7. Intellectual Property

All content, data, scoring methodology, algorithms, and branding on BiotechSign are the exclusive intellectual property of Guerilla Finance Inc., protected by U.S. and international copyright, trademark, and trade secret law. The BiotechSign scoring methodology and data pipelines are proprietary trade secrets. Your access grants you a limited, personal, non-commercial, non-transferable, revocable license to view information through standard browser interactions only. No other rights are granted.

8. Automated Access and Data Harvesting Prohibition

Strictly Prohibited — Legal Action Will Be Taken

BiotechSign collects and maintains PDUFA calendars, clinical trial data, biotech scores, and supply chain intelligence at substantial ongoing expense. This data is proprietary and protected. Automated extraction violates these Terms and applicable federal law.

You may not, directly or through any third party, tool, or service:

  • Use bots, spiders, crawlers, scrapers, or any automated means to access or extract data from the Service;
  • Use headless browsers or browser automation frameworks (Playwright, Puppeteer, Selenium, Scrapy, or equivalents) to harvest from the Service;
  • Programmatically query API endpoints or data feeds at a rate or volume exceeding normal human browsing, or in a pattern consistent with data harvesting;
  • Cache, store, or systematically accumulate PDUFA dates, trial data, scores, or any other data from the Service;
  • Use Service data to train, fine-tune, benchmark, or evaluate AI or machine learning models without a written commercial license;
  • Sell, sublicense, redistribute, or commercialize any data obtained from the Service;
  • Build any competing product, service, or dataset using data obtained from the Service;
  • Reverse-engineer or attempt to derive the BiotechSign scoring methodology or algorithms;
  • Circumvent rate limiting, IP blocks, or any other access controls through proxies, IP rotation, or other means;
  • Place unreasonable or disproportionate load on our servers, APIs, or infrastructure.

Legal Consequences

Unauthorized automated access constitutes unauthorized access to a protected computer under the Computer Fraud and Abuse Act (18 U.S.C. § 1030). Bulk data extraction may constitute misappropriation of trade secrets under the Defend Trade Secrets Act (18 U.S.C. § 1836). Circumventing technical access controls may additionally violate the Digital Millennium Copyright Act (17 U.S.C. § 1201). We actively monitor access patterns and will permanently block offending IPs/ASNs, pursue civil remedies including injunctive relief and attorneys' fees, and refer criminal violations to federal law enforcement.

Technical Enforcement

We employ rate limiting, IP blocking, TLS fingerprinting, behavioral analysis, and honeypot detection. These controls operate at the infrastructure level. Triggering them may result in a permanent block with no appeal. Attempting to circumvent a block is a separate and independent violation of these Terms and applicable law.

9. Acceptable Use

You agree not to: use information from the Service to engage in market manipulation or securities fraud; attempt unauthorized access to backend systems or non-public endpoints; introduce malicious code or denial-of-service attacks; use the Service for any unlawful purpose; or conduct any activity that violates applicable law or regulation.

10. Third-Party Data and Services

BiotechSign integrates data from third-party providers including SEC EDGAR, FDA databases, ClinicalTrials.gov, DilutionWatch, StonkWhisper, and other public sources. Guerilla Finance Inc. is not responsible for:

  • Third-party service outages, disruptions, or API failures;
  • Incorrect, incomplete, delayed, or unavailable data from any third-party source;
  • Changes to FDA database availability, PDUFA date revisions, or clinical trial status changes;
  • The accuracy of underlying data from SEC filings, FDA databases, or ClinicalTrials.gov.

Use of those data sources is subject to their respective terms of service. Always verify clinical and regulatory information from official primary sources.

11. Data Accuracy

Data is sourced from public filings (SEC EDGAR), FDA databases, ClinicalTrials.gov, and third-party partners. While we strive for accuracy, PDUFA dates, trial statuses, and approval probabilities can change without notice. We make no guarantees regarding the completeness, timeliness, or fitness for any purpose of data provided. Always verify information independently before acting on it.

12. AI-Assisted Content

Some content on BiotechSign may be generated or augmented with AI tools. AI-generated content does not constitute investment or medical advice and may contain inaccuracies or errors. Always verify from primary sources including SEC filings and official FDA databases.

13. Force Majeure

Guerilla Finance Inc. shall not be liable for any failure or delay in performance arising from causes beyond its reasonable control, including without limitation: acts of God, natural disasters, pandemic or epidemic, war, terrorism, government action or regulation, power failures, internet or telecommunications outages, third-party service failures, cyberattacks, or FDA/regulatory disruptions. During such events, we may suspend or restrict the Service without notice or liability.

14. Disclaimer of Warranties

THE SERVICE IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT ANY WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ACCURACY, COMPLETENESS, OR RELIABILITY. WE DO NOT WARRANT THAT: (A) THE SERVICE WILL BE UNINTERRUPTED, TIMELY, SECURE, OR ERROR-FREE; (B) ANY DATA, SCORES, PDUFA DATES, OR ANALYTICS ARE ACCURATE, COMPLETE, OR CURRENT; (C) THIRD-PARTY DATA SOURCES WILL BE AVAILABLE OR ACCURATE; (D) DEFECTS WILL BE CORRECTED; OR (E) THE SERVICE IS FREE FROM VIRUSES OR OTHER HARMFUL COMPONENTS. BIOTECH DATA IS INHERENTLY SUBJECT TO RAPID CHANGE AND UNCERTAINTY. YOUR USE OF THE SERVICE IS ENTIRELY AT YOUR OWN RISK.

15. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, GUERILLA FINANCE INC. AND ITS OWNERS, OFFICERS, EMPLOYEES, CONTRACTORS, AND AFFILIATES SHALL NOT BE LIABLE FOR ANY DAMAGES OF ANY KIND ARISING FROM OR RELATED TO YOUR USE OF THE SERVICE, INCLUDING BUT NOT LIMITED TO: TRADING LOSSES, INVESTMENT LOSSES, LOST PROFITS OR REVENUE, LOSS OF CAPITAL, LOSS OF DATA, LOST BUSINESS OPPORTUNITIES, DAMAGES ARISING FROM RELIANCE ON PLATFORM DATA OR ANALYTICS, DAMAGES FROM INVESTMENT OR TRADING DECISIONS, PLATFORM OUTAGES OR DOWNTIME, DELAYED OR INACCURATE INFORMATION, THIRD-PARTY SERVICE FAILURES, FDA DECISIONS OR DELAYS, OR UNAUTHORIZED ACCESS TO YOUR DATA. THIS EXCLUSION APPLIES WHETHER THE CLAIM IS BASED ON CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. OUR TOTAL LIABILITY SHALL NOT EXCEED $50.00.

16. Indemnification

You agree to indemnify, defend, and hold harmless Guerilla Finance Inc. and its owners, officers, employees, contractors, and agents from and against any and all claims, liabilities, damages, judgments, losses, costs, and expenses (including reasonable attorneys' fees) arising from or relating to: (a) your violation of these Terms; (b) your misuse of the Service; (c) any investment or trading decisions you make based on information obtained from the Service; (d) your violation of any applicable law or regulation; or (e) your infringement of any third-party rights.

17. Termination

We may restrict or terminate your access to the Service at any time, for any reason, without notice and without liability — including for violation of these Terms or suspicious access patterns. Termination does not waive our right to pursue legal remedies for past violations.

18. Geographic Restrictions

The Service is operated from the United States and is intended primarily for U.S. audiences. We make no representation that the Service or its content is appropriate or available in any particular jurisdiction outside the United States. If you access the Service from outside the United States, you do so on your own initiative and are solely responsible for compliance with applicable local laws, regulations, and rules. We reserve the right to restrict access from any jurisdiction at any time without notice.

19. Arbitration and Dispute Resolution

Please read this section carefully — it affects your legal rights.

Binding Arbitration

Any dispute, claim, or controversy arising out of or relating to these Terms or your use of the Service shall be resolved exclusively through binding individual arbitration administered under the rules of the American Arbitration Association (AAA), rather than in court, except: (a) you may assert claims in small claims court if your claims qualify; and (b) either party may seek emergency injunctive relief in court to protect intellectual property rights or prevent irreparable harm, pending arbitration.

Class Action Waiver

TO THE MAXIMUM EXTENT PERMITTED BY LAW, YOU WAIVE YOUR RIGHT TO PARTICIPATE IN ANY CLASS ACTION LAWSUIT, CLASS-WIDE ARBITRATION, PRIVATE ATTORNEY GENERAL ACTION, OR ANY OTHER REPRESENTATIVE PROCEEDING AGAINST GUERILLA FINANCE INC. ALL CLAIMS MUST BE BROUGHT ON AN INDIVIDUAL BASIS ONLY.

Any arbitration shall be conducted in Fulton County, Georgia, or remotely by mutual agreement, under the substantive laws of the State of Georgia. The arbitrator's decision shall be final and binding and may be entered as a judgment in any court of competent jurisdiction.

Time Limit

Any claim must be brought within one (1) year of the date the cause of action arose, or it is forever barred. You agree to first contact us at admin@dilutionwatch.com and allow 30 days to attempt informal resolution before initiating arbitration.

20. Modifications to the Service

Guerilla Finance Inc. reserves the right to: (a) modify, update, add, or remove features or functionality of the Service at any time; (b) discontinue the Service or any portion thereof, temporarily or permanently; (c) change data sources, refresh rates, or data coverage without notice; (d) change pricing, subscription terms, or available tiers; and (e) impose limits on certain features or restrict access to all or part of the Service. We shall not be liable to you or any third party for any modification, suspension, or discontinuation of the Service.

21. Severability and Entire Agreement

If any provision of these Terms is found to be unenforceable or invalid, that provision shall be modified to the minimum extent necessary to make it enforceable, and the remaining provisions shall remain in full force and effect. Our failure to enforce any right or provision shall not be deemed a waiver of such right or provision. These Terms, together with our Privacy Policy, constitute the entire agreement between you and Guerilla Finance Inc. regarding the Service and supersede all prior agreements and understandings.

22. Changes to Terms

These terms may be updated at any time. Continued use of the platform after changes constitutes acceptance of the updated terms. Material changes will be reflected in an updated date on this page.

Questions? Contact us at admin@dilutionwatch.com

© 2026 Guerilla Finance Inc. BiotechSign is a product of Guerilla Finance Inc.